Innovation
2 patent families — focus: Chemistry & metallurgy; filing pace dormant. Cited 5 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
Investor mix
15 investors on record; lead investors include Teva Pharmaceuticals, GlenRock Israel, Kadimastem.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 2 | 13% |
| Other / undisclosed | 13 | 87% |